Question 1

What is a Certificate of Analysis (COA)?

Accepted Answer

A Certificate of Analysis is an analytical record for a specific research-compound batch. A finalized Nexus record publishes only the lot-specific fields supported by the underlying evidence, which may include HPLC purity, mass-spectrometry identity fields, additional screens, batch identity, and relevant dates. Pending certificates are labeled pending and do not show assay values.

Question 2

How does Nexus verify peptide purity?

Accepted Answer

Finalized Nexus lot records publish only the reported analytical fields held for that named batch, including reverse-phase HPLC area-percent purity, mass-spectrometry identity fields, and additional panels where present. The public Nexus COA is a normalized record rather than an originating laboratory report or raw instrument file. Pending certificates remain labeled pending and do not expose unfinished assay values.

Question 3

What is HPLC purity testing?

Accepted Answer

High-Performance Liquid Chromatography (HPLC) is a common analytical method for measuring research-peptide purity. A sample is separated through a chromatography column under controlled conditions; the resulting trace can report area-percent purity and retention time. Nexus publishes an HPLC value or method only when that field is present in the finalized lot record.

Question 4

What is mass spectrometry identity confirmation?

Accepted Answer

Mass spectrometry measures mass-to-charge signals that can be compared with the expected molecular mass for a compound. Alignment under the stated method supports a batch identity assessment, but it does not by itself establish complete composition, purity, or net content. Nexus publishes expected and observed mass fields on finalized batch records where those values are present.

Question 5

What does "in-vitro research use only" mean?

Accepted Answer

In-vitro research use means the compound is sold for laboratory experiments conducted outside a living organism — typically in test tubes, well plates, or cell cultures. Compounds labeled in-vitro research use only are not intended for human consumption, veterinary use, or any clinical or therapeutic application. Customers are responsible for ensuring their research complies with applicable institutional, local, state, and federal regulations.

Question 6

How are research peptides stored and handled?

Accepted Answer

Storage and handling conditions vary by compound, format, container, and lot documentation. Laboratories should use a validated internal SOP together with the applicable source or lot record, preserve the product and batch identifiers, and avoid inferring prepared-solution conditions from general catalog copy. Nexus does not provide dosing, administration, or universal reconstitution instructions.

Question 7

How do I place an order?

Accepted Answer

Add research compounds to your cart and proceed to checkout. Nexus currently uses an Ivno-backed secure payment flow with a MoonPay onramp, and ships eligible orders within the United States via USPS.

Question 8

Do you ship outside the United States?

Accepted Answer

No. Nexus Laboratory ships exclusively within the United States. We do not accept international orders.

Question 9

When will my order ship?

Accepted Answer

Orders ship within the United States via USPS. Tracking is sent by email when an order leaves fulfillment.

Question 10

Where can I see the COA for a batch?

Accepted Answer

Products with finalized independent COA records link to the published lot-specific certificate from the product page and the Lab Verified archive. Products awaiting final documentation show a certificate-pending state instead of assay values.

Question 11

What does "lab verified" mean here?

Accepted Answer

Lab Verified means a batch has a finalized analytical record represented by a public Nexus COA. The page shows only the methods and results present for that specific lot; it does not imply that every record contains the same analytical panels. Pending lots are labeled pending and are not framed as finalized certificates.

Question 12

Are these for human use?

Accepted Answer

No. Nexus Laboratory compounds are supplied for in-vitro research use only. Not for human consumption, veterinary use, or any clinical or therapeutic application.

Question 13

What is your refund policy?

Accepted Answer

Eligibility, documentation requirements, exclusions, and timing are governed by the current Shipping & Returns policy. Review that policy before ordering and contact support@nexuslaboratory.org when a shipment, item, or batch record does not match the order documentation.

Question 14

Where is your full regulatory disclaimer?

Accepted Answer

Our full regulatory disclaimer — covering research-use-only status, the absence of FDA or EMA approval, and the compliance responsibilities researchers carry — is published at /legal/regulatory-disclaimer.

Question 15

What is the difference between research-use-only and pharmaceutical-grade?

Accepted Answer

Research-use-only describes the intended laboratory scope: the material is not for human consumption, veterinary use, or clinical or therapeutic application. Terms such as pharmaceutical grade, cGMP, approved, or clinical grade carry different manufacturing and regulatory implications and must not be inferred from a purity value or a research COA. Nexus supplies research-use-only material exclusively.

Question 16

How are research peptides priced compared to clinical-grade?

Accepted Answer

There is no reliable universal price ratio between research-use-only and regulated clinical materials. Nexus publishes the current catalog price for each variant; that price does not imply pharmaceutical grade, cGMP status, regulatory approval, or suitability for human use. Batch-specific analytical fields appear only on finalized public records where those values are present.

Question 17

What does ≥99% purity actually mean in HPLC terms?

Accepted Answer

A reported HPLC purity of ≥99% means that, under the stated method, roughly 99% of the integrated UV-active peak area is assigned to the main peak. It is a relative chromatographic measurement, not absolute mass-percent of the bulk material; water, residual solvents, and non-UV-active material may not be represented. Nexus publishes a method or area-percent result only where the finalized lot record contains that field.

Question 18

How are blends (e.g., BPC-157 + TB-500) analyzed for purity?

Accepted Answer

Blend records must be read component by component and method by method. Do not assume every blend certificate resolves every component with the same analytical treatment. The exact finalized batch record controls which HPLC, mass-spectrometry, identity, or additional-panel fields are public; a pending blend record supports pending status only.

Question 19

How long do lyophilized peptides remain stable?

Accepted Answer

There is no universal shelf-life rule for lyophilized research peptides. Stability depends on sequence, formulation, container closure, moisture, temperature history, and the evidence supporting the specific lot. Use the applicable source or lot record and a validated laboratory SOP; do not infer a prepared-solution lifetime from the lyophilized format or from a neighboring product.

Question 20

What is the difference between acetate and trifluoroacetate (TFA) salt forms?

Accepted Answer

Acetate and trifluoroacetate identify different counterion forms that can affect formula mass, material accounting, solubility behavior, and method interpretation. They should not be assumed interchangeable. Use the exact form named on the product and batch record, and account for the counterion under the laboratory method used for the study.

Question 21

What is a research bioregulator — how does it differ from a peptide hormone?

Accepted Answer

A peptide bioregulator is a short peptide (typically 2-7 amino acids) that participates in tissue-specific regulatory signaling in research models. The category overlaps with peptide hormones — short peptides can act on hormone receptors — but the Khavinson research lineage uses bioregulator to describe peptides whose research-context activity is described as tissue-regulatory or peptide-bioregulator-class rather than acting on a single named hormone receptor. The Khavinson 4-amino-acid bioregulators (e.g., bronchogen, cardiogen, epithalon) are the canonical research representatives of this class. Catalog: /shop/category/russian-bioregulators.

Question 22

Why do Russian bioregulators (Khavinson peptides) have unusual research history?

Accepted Answer

V.Kh. Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology described a family of short tetrapeptide bioregulators starting in the 1970s. The research history is documented largely in Russian biochemistry literature with a different publication-style convention than Western peptide research, which is partly why the Khavinson peptide family is less familiar to Western research audiences than its scope warrants. The 15 Khavinson-family compounds in the Nexus catalog cover the documented organ/tissue-axis research applications. The history is summarized in the peptide research database.

Question 23

What does "fusion protein" mean for compounds like ACE-031?

Accepted Answer

ACE-031 is a fusion protein — specifically, an activin type IIB receptor (ActRIIB) extracellular domain fused to an IgG-Fc immunoglobulin region. The fusion architecture serves two research purposes: the receptor domain provides the binding specificity (activin/myostatin family ligands) and the Fc fusion provides longer in-vitro stability. Fusion proteins differ from simple peptides in their molecular weight, structure, and quality-control requirements — larger proteins require SDS-PAGE and Western blot analysis in addition to mass spectrometry for full characterization.

Question 24

How are CJC-1295 With DAC and Without DAC different?

Accepted Answer

Both compounds are synthetic GHRH analogs. CJC-1295 Without DAC (also marketed as Modified GRF 1-29) is a short-acting research analog with a half-life similar to native GHRH. CJC-1295 With DAC includes a Drug Affinity Complex (DAC) — a maleimidopropionic acid linker enabling covalent binding to serum albumin, dramatically extending the research half-life. The two compounds answer different research questions: short-acting GHRH research uses the no-DAC variant; sustained-signaling research uses the DAC variant. Both compounds appear in the GHRH analogs mechanism family.

Question 25

What information is included in a Nexus Certificate of Analysis?

Accepted Answer

A finalized Nexus COA page is a normalized public batch record. Depending on the fields present for that lot, it can show the compound name, Nexus batch ID, dates, format, reported HPLC area-percent purity, expected and observed mass, additional panels, appearance, storage record, and certificate date. It is not the originating laboratory report or a raw instrument file.

Question 26

What are common research applications for GLP-1 receptor agonists in laboratory studies?

Accepted Answer

GLP-1 receptor agonists are studied in preclinical research models for receptor pharmacology (binding affinity, signaling cascade research), pancreatic beta-cell research, satiety pathway research in animal models, and multi-pathway research using dual (GIP/GLP-1) or triple (GLP-1/GIP/glucagon) agonists. Common comparator research uses semaglutide and tirzepatide side-by-side; multi-agonist research uses retatrutide, mazdutide, and survodutide. All Nexus GLP-1 compounds are supplied for in-vitro research only and no therapeutic or dosing guidance is provided.

Question 27

How do I verify a Nexus batch ID is legitimate?

Accepted Answer

Nexus batch IDs use the format NEX--- and resolve through a dedicated verification URL: /verify/. Published records show finalized batch values and a link to the branded Certificate of Analysis; pending records show certificate-pending status without assay values. If a batch ID does not resolve, or if the data shown does not match the printed record, treat the batch as unverified and contact research support at support@nexuslaboratory.org.

Question 28

What is the difference between semaglutide, tirzepatide, retatrutide, and survodutide?

Accepted Answer

All four are incretin-pathway peptides but with different receptor pharmacology. Semaglutide is a single GLP-1 receptor agonist (the simplest and longest-studied of the four). Tirzepatide is a dual GIP/GLP-1 agonist. Retatrutide is a triple-agonist research compound active at GLP-1, GIP, and glucagon receptors. Survodutide is a dual GLP-1/glucagon agonist. The four are commonly studied as a comparator series in receptor-pharmacology research models examining how added receptor targets change the signaling profile. All are supplied for in-vitro research only.

Question 29

How does Nexus ensure compound stability during USA shipping?

Accepted Answer

Nexus ships via USPS within the United States. Product-specific transit, packaging, cut-off, signature, and temperature-control claims are not stated unless confirmed in the current record. Receiving and storage decisions should follow the laboratory’s validated SOP together with applicable lot or source documentation. Questions can be sent to support@nexuslaboratory.org.

Common questions.

Common questions.

Related resources

Related resources